{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:34:37Z","timestamp":1740123277745,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10637-020-00973-8","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T07:37:50Z","timestamp":1594280270000},"page":"237-239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute tubulointerstitial nephritis induced by the tyrosine kinase inhibitor vandetanib"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-0896","authenticated-orcid":false,"given":"Melissa","family":"Pilco Teran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8322-4047","authenticated-orcid":false,"given":"Ana","family":"Merino Ribas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Martin Alemany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-9769","authenticated-orcid":false,"given":"Xoana","family":"Barros Freiria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-6970","authenticated-orcid":false,"given":"Jordi","family":"Rubio Casadevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"P\u00e9rez Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Garc\u00eda M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Castillo Devia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Noboa Paez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Torguet Escuder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-9539","authenticated-orcid":false,"given":"Jordi","family":"Calabia Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"973_CR1","unstructured":"Drug information: Vandetanib (Caprelsa) prescribing information. (n.d.). Retrieved from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022405s007lbl.pdf"},{"issue":"6","key":"973_CR2","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/er.2019-00007","volume":"40","author":"ME Cabanillas","year":"2019","unstructured":"Cabanillas ME, Ryder M, Jimenez C (2019) Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond. Endocr Rev 40(6):1573\u20131604. https:\/\/doi.org\/10.1210\/er.2019-00007","journal-title":"Endocr Rev"},{"issue":"3","key":"973_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1574892810666150708110816","volume":"10","author":"P Fallahi","year":"2015","unstructured":"Fallahi P, Ferrari S, Bari F, Materazzi G, Benvenga S, Miccoli P, Antonelli A (2015) Cabozantinib in Thyroid Cancer. Recent Pat Anticancer Drug Discov 10(3):259\u2013269. https:\/\/doi.org\/10.2174\/1574892810666150708110816","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"973_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ctrv.2018.04.007","volume":"66","author":"MS Brose","year":"2018","unstructured":"Brose MS, Bible KC, Chow LQM, Gilbert J, Grande C, Worden F, Haddad R (2018) Management of treatment-related toxicities in advanced medullary thyroid cancer. Cancer Treat Rev 66:64\u201373. https:\/\/doi.org\/10.1016\/j.ctrv.2018.04.007","journal-title":"Cancer Treat Rev"},{"key":"973_CR5","doi-asserted-by":"publisher","unstructured":"Wells SA, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, \u2026 Schlumberger MJ (2012) Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: A randomized, double-blind phase III trial. J Clin Oncol 30(2):134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2011.35.5040","DOI":"10.1200\/JCO.2011.35.5040"},{"issue":"10","key":"973_CR6","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/ndt\/gft241","volume":"28","author":"M Airy","year":"2013","unstructured":"Airy M, Raghavan R, Truong LD, Eknoyan G (2013) Tubulointerstitial nephritis and cancer chemotherapy: Update on a neglected clinical entity. Nephrol Dial Transplant 28(10):2502\u20132509. https:\/\/doi.org\/10.1093\/ndt\/gft241","journal-title":"Nephrol Dial Transplant"},{"key":"973_CR7","doi-asserted-by":"publisher","unstructured":"Winn SK, Ellis S, Savage P, Sampson S, Marsh JE (2009) Biopsy-proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib: A class effect? Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfn625","DOI":"10.1093\/ndt\/gfn625"},{"issue":"5","key":"973_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/009286150804200501","volume":"42","author":"M Lindquist","year":"2008","unstructured":"Lindquist M (2008) VigiBase, the WHO Global ICSR Database System: Basic facts. Drug Inf J 42(5):409\u2013419. https:\/\/doi.org\/10.1177\/009286150804200501","journal-title":"Drug Inf J"},{"key":"973_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrneph.2010.71","volume":"6","author":"MA Perazella","year":"2010","unstructured":"Perazella MA, Markowitz GS (2010) Drug-induced acute interstitial nephritis. Nature Reviews Nephrology 6:461\u2013470. https:\/\/doi.org\/10.1038\/nrneph.2010.71","journal-title":"Nature Reviews Nephrology"},{"key":"973_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12882-019-1277-2","volume":"20","author":"D Yun","year":"2019","unstructured":"Yun D, Jang MJ, An JN, Lee JP, Kim DK, Chin HJ, Han SS (2019) Effect of steroids and relevant cytokine analysis in acute tubulointerstitial nephritis. BMC Nephrol 20:88. https:\/\/doi.org\/10.1186\/s12882-019-1277-2","journal-title":"BMC Nephrol"},{"issue":"7","key":"973_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/qjmed\/hcu236","volume":"108","author":"A Valluri","year":"2015","unstructured":"Valluri A, Hetherington L, McQuarrie E, Fleming S, Kipgen D, Geddes CC, Bell S (2015) Acute tubulointerstitial nephritis in Scotland. QJM 108(7):527\u2013532. https:\/\/doi.org\/10.1093\/qjmed\/hcu236","journal-title":"QJM"},{"issue":"8","key":"973_CR12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.ki.5002776","volume":"73","author":"E Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez E, Guti\u00e9rrez E, Galeano C, Chevia C, De Sequera P, Bernis C, Praga M (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73(8):940\u2013946. https:\/\/doi.org\/10.1038\/sj.ki.5002776","journal-title":"Kidney Int"},{"key":"973_CR13","doi-asserted-by":"publisher","unstructured":"Clarkson MR, Giblin L, O\u2019Connell FP, O\u2019Kelly P, Walshe JJ, Conlon P, \u2026 Donohoe J (2004) Acute interstitial nephritis: Clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19(11):2778\u20132783. https:\/\/doi.org\/10.1093\/ndt\/gfh485","DOI":"10.1093\/ndt\/gfh485"},{"issue":"4","key":"973_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","volume":"64","author":"AK Muriithi","year":"2014","unstructured":"Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, Nasr SH (2014) Biopsy-proven acute interstitial nephritis, 1993\u20132011: A case series. Am J Kidney Dis 64(4):558\u2013566. https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.027","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"973_CR15","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2215\/CJN.12001018","volume":"13","author":"DG Moledina","year":"2018","unstructured":"Moledina DG, Perazella MA (2018) Treatment of drug-induced acute tubulointerstitial nephritis: The search for better evidence. Clin J Am Soc Nephrol 13(12):1785\u20131787. https:\/\/doi.org\/10.2215\/CJN.12001018","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-020-00973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-020-00973-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-020-00973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:53:05Z","timestamp":1678510385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-020-00973-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s10637-020-00973-8","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors including in this paper declares that them not have conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}